Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

August 31, 2007

Conditions
Community-Acquired Pneumonia
Interventions
DRUG

TG-873870(Nemonoxacin)

Trial Locations (20)

114

Chang-Hua Christian Hospital, Changhua

E-Da Hospital, Kaohsiung City

Kaoshiung Medical University Hospital, Kaoshiung

Cheng Ching Hospital, Taichung

Taichung Veterans General Hospital, Taichung

Chi-Mei Foundation Hospital, Tainan City

Buddhist Taipei Tzu Chi General Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Tri-Service General Hospital, Taipei

Chang-Gung Memorial Hospital, Taoyuan District

Unknown

GCT at Jubilee Hospital, Temba

Benmed/Pentagon Hospital, Benomi

MediTrials, Cape Town

Private, Kimberley

DJW Research, Krugersdorp

GCT Trial Centre, Mercantile Hospital, Port Elizabeth

Private, Potchefstroom

Bougainville Hospital, Pretoria

de Villers Clinical Trials, Scottburgh

Park Medical Centre, Witbank

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

TaiGen Biotechnology Co., Ltd.

INDUSTRY

NCT00434291 - Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia | Biotech Hunter | Biotech Hunter